Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
Abstract: This article investigates the robust consensus scheme for a specific type of leader-follower multiagent systems (MASs) in the context of a human-cyber–physical interactive system. The system ...
Hosted on MSN
Cathie Wood’s ARK Investment buys 755K shares of Recursion Pharmaceuticals, Inc. (RXRX)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 12 Best Genomics Stocks to Invest In. Cathie Wood’s ARK Investment acquired 755,000 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback